{"schema_version":"secwatch.filing_event.v1","accession":"0000885590-26-000089","form_type":"8-K","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2026-07-01T20:23:22+00:00","discovered_at":"2026-07-01T20:24:01.134386+00:00","generated_at":"2026-07-01T20:24:04.459149+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Michael Goettler resigns from Bausch Health board to become CEO of Knoa Pharma","bullets":["Resignation effective June 30, 2026, due to appointment as President and CEO of Knoa Pharma LLC.","Mr. Goettler's departure was not due to any disagreement with the company.","Press release announcing the resignation was issued on July 1, 2026.","No other material changes to the board or management disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000885590-26-000089","json":"https://secwatch.observer/filing/0000885590-26-000089.json","markdown":"https://secwatch.observer/filing/0000885590-26-000089.md","text":"https://secwatch.observer/filing/0000885590-26-000089.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000089/0000885590-26-000089-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000089/bhc-20260626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T20:24:04.459149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9ec801062","claim":"Michael Goettler resigned as Director at Bausch Health Companies Inc..","evidence_excerpt":"On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000089/0000885590-26-000089-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}